Ok
Cancel
Don't show this message again
-
Ok CancelDon't show this message again
Experimental Drugs, Marijuana, and Complementary Medication Use in Long-Term Care Settings: Risks and Best Practices
Aleah Schutze, Of Counsel, Steptoe & Johnson PLLC. Sarah Potter, Associate General Counsel, BrightSpring Health Services.
April 9, 2019
-
Identify and address issues around who can administer experimental and complementary medications as well as marijuana and CBD/Hemp oil
-
Discussion of storage and access to marijuana, experimental, and complementary medications
-
Identify and address the legal risks associated with patient use of marijuana, experimental, and complementary medications in long‑term care facilities
-